According to Spero Therapeutics's latest financial reports the company's current revenue (TTM) is $96.73 M. In 2022 the company made a revenue of $48.57 M an increase over the years 2021 revenue that were of -$9.63 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $96.73 M | 99.13% |
2022 | $48.57 M | -604.56% |
2021 | -$9.63 M | -3831.78% |
2020 | $0.25 M | -97.72% |
2019 | $11.3 M | 2341.04% |
2018 | $0.46 M | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
IBM IBM | $61.85 B | 63,846.87% | ๐บ๐ธ USA |
Thomson Reuters
TRI | $6.79 B | 6,923.31% | ๐จ๐ฆ Canada |
Franklin Covey FC | $0.27 B | 188.55% | ๐บ๐ธ USA |